Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06957821) titled 'Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques' on May 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Other. Masking: Single (Outcomes Assessor).
Primary Sponsor: Massachusetts General Hospital
Condition:
Carotid Artery Diseases
Peripheral Arterial Disease
Intervention:
Drug: Pegulicianine
Recruitment Status: Not recruiting
Phase: Early Phase 1
Date of First Enrollment: May 30, 2025
Target Sample Size: 25
Countries of Recruitment:
United States
To know more, visit htt...